- Home
- TRML vs TRC Comparison
TRML vs TRC Comparison
Compare TRML & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- TRC
- Stock Information
- Founded
- TRML 2021
- TRC 1843
- Country
- TRML United States
- TRC United States
- Employees
- TRML N/A
- TRC N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- TRC Real Estate
- Sector
- TRML Health Care
- TRC Finance
- Exchange
- TRML Nasdaq
- TRC Nasdaq
- Market Cap
- TRML 419.1M
- TRC 455.3M
- IPO Year
- TRML N/A
- TRC N/A
- Fundamental
- Price
- TRML $27.66
- TRC $16.46
- Analyst Decision
- TRML Strong Buy
- TRC
- Analyst Count
- TRML 3
- TRC 0
- Target Price
- TRML $64.67
- TRC N/A
- AVG Volume (30 Days)
- TRML 202.3K
- TRC 88.4K
- Earning Date
- TRML 11-07-2024
- TRC 11-19-2024
- Dividend Yield
- TRML N/A
- TRC N/A
- EPS Growth
- TRML N/A
- TRC N/A
- EPS
- TRML N/A
- TRC N/A
- Revenue
- TRML N/A
- TRC $40,118,000.00
- Revenue This Year
- TRML N/A
- TRC N/A
- Revenue Next Year
- TRML N/A
- TRC $18.51
- P/E Ratio
- TRML N/A
- TRC N/A
- Revenue Growth
- TRML N/A
- TRC N/A
- 52 Week Low
- TRML $12.12
- TRC $14.80
- 52 Week High
- TRML $48.31
- TRC $19.82
- Technical
- Relative Strength Index (RSI)
- TRML 58.78
- TRC 48.67
- Support Level
- TRML $25.10
- TRC $16.41
- Resistance Level
- TRML $28.35
- TRC $17.53
- Average True Range (ATR)
- TRML 1.37
- TRC 0.33
- MACD
- TRML -0.26
- TRC 0.10
- Stochastic Oscillator
- TRML 57.98
- TRC 42.20
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely commercial/industrial real estate development, resort/residential real estate development, mineral resources, farming, and ranch operations.